The Independent New prostate cancer drug showing ‘remarkable’ results during clinical trial
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour
The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour